NOVARTIS

NOVARTIS

Displaying 10 out of 67 results

  1. FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illu

    Roche sets sights on Novartis, Biogen as SMA trial hits target

    Roche's bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug ...
  2. New Content Item

    Novartis gets US nod for long-delayed Amgen copycat

  3. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis says delayed telling FDA of Zolgensma concern due to 'mistake'

    Novartis scientists learnt months ago about safety concerns surrounding its gene therapy Zolgensma but delayed telling the U.S. Food and Drug ...
  4. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis arthritis drug fails to prove it is significantly better than rival

    A clinical trial of Novartis's Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the ...
  5. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis' Zolgensma study halted by FDA amid safety questions

    U.S. regulators have halted a trial of Novartis's Zolgensma treatment after an animal study raised safety concerns, the company said on Wednesday, ...
  6. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis data suggest payers getting breaks on gene therapy Zolgensma

    Novartis sales data on Tuesday suggested the Swiss drugmaker is reaping less than the US$2.1 million U.S. list price for its gene therapy ...
  7. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    Novartis gets FDA boost in crowded eye drug market

    Novartis has received approval from the U.S. Food and Drug Administration for its Beovu drug to treat a cause of vision loss, the Swiss ...
  8. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    Novartis says Kisqali boosts survival in breast cancer patients

    Novartis said on Sunday that Kisqali helped women with advanced breast cancer after menopause live longer, adding to data the Swiss company hopes ...
  9. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    Novartis blames former AveXis executives for Zolgensma data manipulation

    Novartis AG blamed former executives Brian and Allan Kaspar for the manipulation of data behind its US$2.1 million gene therapy Zolgensma, saying ...
  10. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    British baby's death not due to SMA gene therapy: Novartis

    A British baby's death this year after getting Novartis's gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker ...